Insulet Corporation (PODD) Institutional Ownership & Insider Trading

725 institutions reported holding Insulet Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 8 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PODDInsulet CorporationFollow PODD — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 10.3B
P/E TTM: 27.9
Dividend yield: —
52-week: —
Next earnings: 4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

725 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +1.5%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	725	72	+1.5%	315	67	242	122
Mar 26	780	70	+0.3%	302	53	245	101
Dec 25	816	70	+0.8%	296	63	230	71
Sep 25	795	68	-1.3%	298	70	210	61
Jun 25	782	70	-1.3%	261	113	231	35
Mar 25	694	70	+0.1%	267	67	198	34
Dec 24	665	70	-1.5%	217	69	200	39
Sep 24	605	70	-0.5%	202	71	215	51

Insulet Corporation — questions

Who owns Insulet Corporation stock?: 725 institutions reported Insulet Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (9.7%), VANGUARD CAPITAL MANAGEMENT LLC (6.5%), STATE STREET CORP (4.6%).
Are Insulet Corporation insiders buying or selling?: 8 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Insulet Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.